Results 1 to 10 of about 1,617 (203)

TMVR after TA-TAVR: a re-redo surgery—case report [PDF]

Frontiers in Cardiovascular Medicine
IntroductionTranscatheter mitral valve replacement (TMVR) is a valuable treatment option in patients with severe mitral regurgitation. Prior transapical transcatheter aortic valve replacement (TA-TAVR) may complicate the procedure and is therefore ...
Inga Voges, Stephanie Sellers, Thomas Puehler   +2 more
exaly   +7 more sources

The outcomes of valve-in-valve TMVR for patients with mitral bioprosthetic valve dysfunction: a single-center retrospective study [PDF]

Frontiers in Cardiovascular Medicine
ObjectiveTo explore the clinical efficacy and follow-up results of the valve-in-valve transcatheter mitral valve replacement (TMVR) technique in patients with mitral bioprosthetic valve dysfunction.MethodsThe medical data of patients with biological ...
Tao Zhang, Yahua Li, Bin Lin, Li Li, Bowen Lian, Pengju Guo, Xiaoyan Zhao   +6 more
doaj   +2 more sources

Valve‐in‐Valve Transcatheter Mitral Valve Replacement Versus Redo Surgical Mitral Valve Replacement: Meta‐Analysis of Early and Late Outcomes [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Bioprosthetic mitral valve degeneration is traditionally treated with redo surgical mitral valve replacement (redo‐SMVR), but valve‐in‐valve transcatheter mitral valve replacement (ViV‐TMVR) offers a less invasive alternative.
Michel Pompeu Sá, Gabriel Neves, Leo Consoli, Asad Iqbal, Leonardo Dexheimer, David Abraham Batista da Hora, Thiago Camarotti, Xander Jacquemyn, Federico Napoli, Antonio Polanco, Nicolas A. Brozzi, Jose L. Navia   +11 more
doaj   +2 more sources

Real-world outcomes of TMVR-eligible and TMVR-ineligible patients

European Heart Journal - Imaging Methods and Practice
Abstract Aims Over the past decade, transcatheter valve replacement has emerged as a therapy for selected patients with valvular heart. Clinical experience with transcatheter mitral valve replacement (TMVR) has been limited to date and provides little insight into its potential as a viable ...
Michele De Bonis, Roberto Lorusso, Paolo Denti   +2 more
exaly   +4 more sources

Cost-Effectiveness of Valve-in-Valve Transcatheter Mitral Valve Replacement Versus Redo Surgical Mitral Valve Replacement for Degenerated Bioprosthetic Mitral Valve [PDF]

Structural Heart
Background: Degenerated bioprosthetic mitral valves (MVs) are associated with significant morbidity and health care expenditures. For certain patients, valve-in-valve transcatheter MV replacement (ViV TMVR) has emerged as a promising treatment option due
Elina E. Pliakos, MD, Kriyana Reddy, BS, Pavan Atluri, MD, Howard C. Herrmann, MD, Paul Fiorilli, MD, Mohamad Alkhouli, MD, MBA, Suzanne J. Baron, MD, Jay Giri, MD, Ashwin S. Nathan, MD   +8 more
doaj   +2 more sources

ELASTACLIP and TMVR for Failed TEER With Leaflet Tear. [PDF]

JACC Case Rep
Severe mitral regurgitation (MR) after unsuccessful mitral transcatheter edge-to-edge repair (M-TEER) is relatively uncommon. Elderly comorbid patients may have limited options for definitive MR treatment after failed TEER.A 72-year-old woman with dilated cardiomyopathy presented with symptomatic severe functional MR and underwent M-TEER.
Gamal A, Almalki Y, Attumalil T, Bagai A, Ong G, Bisleri G, Alnasser S, Fam NP.   +7 more
europepmc   +3 more sources

TMVR for the Treatment of Mitral Regurgitation: A State-of-the-Art Review. [PDF]

Circ Cardiovasc Interv
Mitral regurgitation is the most common valve disease worldwide. Despite its wide success in inoperable or high-risk surgical patients, transcatheter edge-to-edge repair remains limited by some anatomic features and the non-negligible rate of significant residual regurgitation.
Tartaglia F, Antonelli G, Gitto M, Stankowski K, Donia D, Stefanini G, Latib A, Colombo A, Mangieri A, Chiarito M.   +9 more
europepmc   +3 more sources

Association of Transcatheter Mitral Valve Repair Availability With Outcomes of Mitral Valve Surgery

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Transcatheter mitral valve repair (TMVr) is currently offered at selected centers that meet certain operator and institutional requirements. We sought to explore the hypothesis that the availability of TMVr is associated with improved outcomes
Mohamad Alkhouli, Fahad Alqahtani, Akram Kawsara, Mayra Guerrero, Mackram F. Eleid, Vuyisile T. Nkomo, Charanjit S. Rihal, Juan A. Crestanello   +7 more
doaj   +1 more source

Neo‐LVOT measurement in TMVR: time for Multimodality?

Echocardiography
Anna Giulia Pavon, Marco Guglielmo
exaly   +5 more sources

Minimally invasive treatment of mitral valve disease with severe mitral annular calcificationCentral MessagePerspective

JTCVS Techniques, 2023
Objective: Mitral valve disease in presence of severe mitral annular calcification (MAC) remains a challenge for surgeons to address. Conventional surgical techniques have potential for heightened morbidity and mortality.
Andrew D. Wisneski, MD, Barbara Hamilton, MD, Tom C. Nguyen, MD   +2 more
doaj   +1 more source